CA1126274A - Triazolylbenzophenone derivatives and production thereof - Google Patents

Triazolylbenzophenone derivatives and production thereof

Info

Publication number
CA1126274A
CA1126274A CA260,438A CA260438A CA1126274A CA 1126274 A CA1126274 A CA 1126274A CA 260438 A CA260438 A CA 260438A CA 1126274 A CA1126274 A CA 1126274A
Authority
CA
Canada
Prior art keywords
triazol
benzophenone
alkyl
chloro
represents hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA260,438A
Other languages
English (en)
French (fr)
Inventor
Kentaro Hirai
Toshio Fujishita
Teruyuki Ishiba
Hirohiko Sugimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of CA1126274A publication Critical patent/CA1126274A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/92Oxygen atoms with hetero atoms directly attached to nitrogen atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA260,438A 1975-12-30 1976-09-02 Triazolylbenzophenone derivatives and production thereof Expired CA1126274A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB53224/75A GB1531980A (en) 1975-12-30 1975-12-30 Triazolylbenzophenone derivatives and preparation thereof
GB53224/75 1975-12-30

Publications (1)

Publication Number Publication Date
CA1126274A true CA1126274A (en) 1982-06-22

Family

ID=10467048

Family Applications (1)

Application Number Title Priority Date Filing Date
CA260,438A Expired CA1126274A (en) 1975-12-30 1976-09-02 Triazolylbenzophenone derivatives and production thereof

Country Status (19)

Country Link
JP (1) JPS5283469A (de)
AR (2) AR218613A1 (de)
AT (1) AT350052B (de)
AU (1) AU498113B2 (de)
BE (1) BE846410A (de)
CA (1) CA1126274A (de)
CH (1) CH623315A5 (de)
DE (1) DE2641164A1 (de)
DK (1) DK393576A (de)
ES (3) ES451896A1 (de)
FR (1) FR2336930A1 (de)
GB (1) GB1531980A (de)
HU (1) HU172539B (de)
IE (1) IE43841B1 (de)
IL (1) IL50664A (de)
NL (1) NL7610799A (de)
NZ (1) NZ181958A (de)
SE (1) SE7609813L (de)
ZA (1) ZA765851B (de)

Also Published As

Publication number Publication date
NL7610799A (nl) 1977-07-04
GB1531980A (en) 1978-11-15
CH623315A5 (en) 1981-05-29
ATA684276A (de) 1978-10-15
ZA765851B (en) 1977-09-28
AU1749876A (en) 1978-03-16
DE2641164A1 (de) 1977-07-14
DK393576A (da) 1977-07-01
ES451896A1 (es) 1978-01-16
JPS5283469A (en) 1977-07-12
IL50664A (en) 1983-09-30
SE7609813L (sv) 1977-07-01
AT350052B (de) 1979-05-10
IE43841B1 (en) 1981-06-03
IE43841L (en) 1977-06-30
ES462244A1 (es) 1978-06-01
AR218613A1 (es) 1980-06-30
BE846410A (fr) 1977-01-17
IL50664A0 (en) 1976-12-31
ES462243A1 (es) 1978-06-01
AU498113B2 (en) 1979-02-08
NZ181958A (en) 1979-03-28
AR220519A1 (es) 1980-11-14
HU172539B (hu) 1978-09-28
FR2336930A1 (fr) 1977-07-29
FR2336930B1 (de) 1978-12-22

Similar Documents

Publication Publication Date Title
AU746707B2 (en) Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them
US5840699A (en) Peptide derivatives
CA2008116C (en) Glycine derivatives
IE60128B1 (en) Hydroxylamine derivatives,their preparation and use as medicaments
US4749687A (en) Renin inhibitors containing statine or derivatives thereof
TW200810777A (en) Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
JPS61183253A (ja) 新規なペプチダ−ゼ阻害剤
NZ244985A (en) Peptide compounds, preparation and pharmaceutical compositions thereof
WO1991015487A1 (fr) Nouveau derive de 4-1-benzoxazine-4h-3,1
JP2004527548A (ja) カスパーゼ阻害剤としての複素環ジカルバミド
SE447389B (sv) Nya tripeptider, som inverkar pa det centrala nervsystemet
TW201536793A (zh) Bace抑制劑
KR960010349B1 (ko) 2, 3-이치환된 이속사졸리딘, 그의 제조방법, 그를 함유하는 제제 및 그의 용도
JPS6210519B2 (de)
JPH08505846A (ja) 血小板凝集阻害用化合物
EP0506628A2 (de) Aminoacyl und Oligopeptidylderivate von Allopurinol mit immunostimulierender Wirkung und diese enthaltende pharmazeutische Zubereitungen
US4141901A (en) Process for producing triazolylbenzophenone derivatives
US4104371A (en) Psychopharmacologically active peptides and peptide-derivatives, and the use thereof
US4110322A (en) Peptide derivatives and pharmaceutical compositions containing same
WO1992018488A1 (fr) Nouveau derive d'oxazinone
US4299821A (en) Tripeptides acting on the central nervous system and a process for the preparation thereof
CA1126274A (en) Triazolylbenzophenone derivatives and production thereof
CHATURVEDI et al. Topochemically related hormone structures: synthesis of partial retro‐inverso analogs of LH‐RH
US3856770A (en) Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
US3723406A (en) Novel peptides having cholecystokinin activity and intermediates therefor

Legal Events

Date Code Title Description
MKEX Expiry